Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=sgenLatest Financial News for Seattle Genetics, Inc.en-usWed, 23 Dec 2009 21:12:10 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091223/sgen8-k.htmlyahoo_finance/4039448736Wed, 23 Dec 2009 21:12:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=1401m1ugn/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/seattle-genetics-collaborate-glaxosmithkline-antibody-drugs/yahoo_finance/2695593815Tue, 22 Dec 2009 00:22:55 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091221/2661_id.html?.v=1Some big names got into the action on Monday.yahoo_finance/4129327475Mon, 21 Dec 2009 15:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12b8dt988/*http%3A//triangle.bizjournals.com/triangle/stories/2009/12/21/daily1.html?ana=yfcpcyahoo_finance/70011012Mon, 21 Dec 2009 15:05:11 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh54974_2009-12-21_13-14-34_sge5bk0eo_newsml&rpc=44&type=marketsNewsyahoo_finance/1843819459Mon, 21 Dec 2009 13:14:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091221/20091221005148.html?.v=1BOTHELL, Wash.----Seattle Genetics, Inc. , announced today that it has entered into a collaboration agreement with GlaxoSmithKline under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ antibody-drug conjugate technology with multiple antigens to be named by GSK.yahoo_finance/2790385625Mon, 21 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=138muh5qu/*http%3A//seekingalpha.com/article/179031-seattle-genetics-gets-boost-from-cancer-drug-deal-with-takeda?source=yahooyahoo_finance/796577846Sun, 20 Dec 2009 12:10:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12omf6q0g/*http%3A//seekingalpha.com/article/179029-this-week-s-biotech-deal-making-and-financing?source=yahooyahoo_finance/3460268445Sun, 20 Dec 2009 12:02:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=129ue0adv/*http%3A//seattle.bizjournals.com/seattle/stories/2009/12/14/daily9.html?ana=yfcpcyahoo_finance/3871302623Tue, 15 Dec 2009 17:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128co2tij/*http%3A//boston.bizjournals.com/boston/stories/2009/12/14/daily19.html?ana=yfcpcyahoo_finance/2119248387Tue, 15 Dec 2009 16:05:18 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/sgen8-k.htmlyahoo_finance/3532856317Tue, 15 Dec 2009 11:06:33 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=145rms8u2/*http%3A//www.thestreet.com/_yahoo/story/10645731/1/safety-dogs-elan-alzheimers-drug-seattle-genetics-finds-new-partner-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2408387390Tue, 15 Dec 2009 11:00:50 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh81643_2009-12-15_09-25-21_toe5be07a_newsml&rpc=44&type=marketsNewsyahoo_finance/2832189825Tue, 15 Dec 2009 09:25:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091215/20091214006411.html?.v=1BOTHELL, Wash. & CAMBRIDGE, Mass. & OSAKA, Japan----Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin .yahoo_finance/3678346456Tue, 15 Dec 2009 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091214/20091214006350.html?.v=1SEATTLE----Seattle Genetics, Inc. , today announced that its management will host a teleconference at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time on Tuesday, December 15, 2009, to discuss brentuximab vedotin partnering.yahoo_finance/1035011685Tue, 15 Dec 2009 00:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12auh5g62/*http%3A//seattle.bizjournals.com/seattle/stories/2009/12/07/daily43.html?ana=yfcpcyahoo_finance/2274768995Fri, 11 Dec 2009 18:05:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091211/us_seattle_genetics_genentech.html?.v=1Development-stage biotechnology company Seattle Genetics Inc. said Friday Genentech has ended a collaboration to develop the cancer treatment dacetuzumab.yahoo_finance/1674685887Fri, 11 Dec 2009 14:16:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12klhcjd7/*http%3A//www.marketwatch.com/news/story/eads-ncr-seattle-genetics-focus/story.aspx?guid=%7B09C6158F%2D0E48%2D430B%2D8DBA%2D00BBBB31E1D8%7D&siteid=yhoofA roundup of financial and business news breaking before the opening bell on Wall Street.yahoo_finance/2133128352Fri, 11 Dec 2009 13:44:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13jjffmfo/*http%3A//www.thestreet.com/_yahoo/story/10643771/1/roche-seattle-genetics-part-ways-on-lymphoma-drug-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3237845852Fri, 11 Dec 2009 12:06:04 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091211/sgen8-k.htmlyahoo_finance/41715065Fri, 11 Dec 2009 12:03:32 Etc/GMT